MedPath

The Governing Council of the University of Toronto

The Governing Council of the University of Toronto logo
🇨🇦Canada
Ownership
Private
Established
1827-03-15
Employees
10K
Market Cap
-
Website
http://www.utoronto.ca

Cardiovascular Health And Risk Modification in Family Health Teams

Phase 3
Completed
Conditions
Diabetes
Hypertension
Hyperlipidemia
Cardiovascular Risk Factors
Interventions
Behavioral: Active risk factor surveillance
First Posted Date
2008-11-07
Last Posted Date
2018-04-03
Lead Sponsor
University of Toronto
Target Recruit Count
229
Registration Number
NCT00787306
Locations
🇨🇦

Granovsky Gluskin Family Medicine Cwntre, Toronto, Ontario, Canada

Vitamin D Effects on Prostate Pathology

Phase 2
Conditions
Prostate Cancer
Interventions
Dietary Supplement: vitamin D3 (cholecalciferol)
First Posted Date
2008-08-26
Last Posted Date
2011-09-30
Lead Sponsor
University of Toronto
Target Recruit Count
90
Registration Number
NCT00741364
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight

Not Applicable
Completed
Conditions
Overweight
Diabetes
Obesity
Metabolic Syndrome
Hypertension
Interventions
Other: navy beans added to regular diet
First Posted Date
2008-08-26
Last Posted Date
2012-06-15
Lead Sponsor
University of Toronto
Target Recruit Count
14
Registration Number
NCT00741923
Locations
🇨🇦

Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada

The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot Study

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Cardiovascular Disease
Obesity
Interventions
Behavioral: Dietary Intervention (Macronutrient composition)
First Posted Date
2008-06-30
Last Posted Date
2010-01-20
Lead Sponsor
University of Toronto
Target Recruit Count
60
Registration Number
NCT00707460
Locations
🇨🇦

Sandy Lake Health & Diabetes Project Research Office, Sandy Lake, Ontario, Canada

Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Dietary Supplement: Vitamin D3
First Posted Date
2008-03-27
Last Posted Date
2008-03-28
Lead Sponsor
University of Toronto
Target Recruit Count
49
Registration Number
NCT00644904
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study

Withdrawn
Conditions
Cholangiocarcinoma
First Posted Date
2008-01-30
Last Posted Date
2017-05-04
Lead Sponsor
University of Toronto
Registration Number
NCT00604266
Locations
🇨🇦

UHN - Princess Margaret Hospital, Toronto, Ontario, Canada

Postpartum Depression Prevention Trial

Not Applicable
Completed
Conditions
Postpartum Depression
Interventions
Behavioral: Peer support
First Posted Date
2008-01-30
Last Posted Date
2015-06-03
Lead Sponsor
University of Toronto
Target Recruit Count
702
Registration Number
NCT00604604
Locations
🇨🇦

Peel Health Department, Mississauga, Ontario, Canada

🇨🇦

Halton Region Health Department, Oakville, Ontario, Canada

🇨🇦

Ottawa Public Health, Ottawa, Ontario, Canada

and more 4 locations

The Effect of Eating Pulses for 8 Weeks on Satiety and Metabolic Syndrome Risk Factors in Overweight Individuals

Not Applicable
Completed
Conditions
Obesity
Overweight
Interventions
Other: Dietary advise
Other: Diet enriched with a meal containing pulses
First Posted Date
2008-01-30
Last Posted Date
2012-06-15
Lead Sponsor
University of Toronto
Target Recruit Count
44
Registration Number
NCT00604448
Locations
🇨🇦

Leadership Sinai Centre for Diabetes, Mt. Sinai Hospital, Toronto, Ontario, Canada

Effects of Acetaminophen on Hurt Feelings

Not Applicable
Completed
Conditions
Emotional Pain
Interventions
Other: cornstarch
First Posted Date
2007-11-20
Last Posted Date
2008-06-25
Lead Sponsor
University of Toronto
Target Recruit Count
60
Registration Number
NCT00561288
Locations
🇨🇦

University of Toronto, Toronto, Ontario, Canada

Atorvastatin for the Treatment of Retinal Vein Occlusion

Phase 3
Conditions
Retinal Vein Occlusion
Central Retinal Vein Occlusion
Retinal Vein Thrombosis
Branch Retinal Vein Occlusion
Thrombosis
Interventions
Drug: Placebo
First Posted Date
2007-08-16
Last Posted Date
2008-06-25
Lead Sponsor
University of Toronto
Target Recruit Count
180
Registration Number
NCT00517257
Locations
🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath